Why Ozempic Doesn't Work for Everyone cover art

Why Ozempic Doesn't Work for Everyone

Why Ozempic Doesn't Work for Everyone

By: Inception Point AI
Listen for free

Summary

 Dr. Ben Synth reveals why up to 15% of patients see little benefit from Ozempic and similar GLP-1 medications, exploring genetic factors, gut microbiome differences, and real-world adherence challenges. Discover the cutting-edge science explaining who responds to these blockbuster weight-loss drugs and who doesn't. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI.Copyright 2026 Inception Point AI Hygiene & Healthy Living Physical Illness & Disease Science
Episodes
  • Why Ozempic Doesn't Work for Everyone - Unpack the science behind the hype with Dr. Ben Synth

    Why Ozempic Doesn't Work for Everyone - Unpack the science behind the hype with Dr. Ben Synth
    Apr 7 2026
    Join Dr. Ben Synth as he uncovers why Ozempic works like magic for some but fails for others—exploring DNA, gut bacteria, dropout rates, and real-world factors clinical trials miss. If you're considering GLP-1 drugs, this series reveals the critical science behind personalized weight loss nobody's talking about. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV
    Show More Show Less
    1 min
  • Why Ozempic Doesn't Work for Everyone - The 68% Who Quit

    Why Ozempic Doesn't Work for Everyone - The 68% Who Quit
    Apr 7 2026
    Host Ben Synth examines why 68% of patients discontinue Ozempic or Wegovy within one year, exploring cost barriers, side effects, dosing gaps, and metabolic plateaus driving mass discontinuation. Covers real-world adherence data showing weight regain after stopping, financial obstacles, and systemic failures underlying the GLP-1 dropout crisis.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI

    This episode includes AI-generated content.
    Show More Show Less
    27 mins
  • Why Ozempic Doesn't Work for Everyone - The Gut Bacteria Wildcard

    Why Ozempic Doesn't Work for Everyone - The Gut Bacteria Wildcard
    Apr 7 2026
    Ben Synth explores how gut bacteria may determine GLP-1 drug effectiveness, examining research on microbiome diversity, beneficial species like Akkermansia muciniphila, and why Ozempic works dramatically for some while failing others. Discover the hidden biological factors behind response variability in this science-driven investigation.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI

    This episode includes AI-generated content.
    Show More Show Less
    21 mins
adbl_web_anon_alc_button_suppression_c
No reviews yet